While factors like age, sex, and comorbidities are known to influence COVID-19 outcomes, and variations in healthcare systems and public health responses can impact disease presentation and severity, the consistent association of elevated GRP78 with a more severe clinical profile across both cohorts is particularly noteworthy [7,28]. Here, HSPA5 is linked to COVID-19.